Category Archives: Prostate Cancer

ProVent Study

ProVent Study is a randomized Phase 3, Open-label Trial of Sipuleucel-T administered to patients on active surveillance for newly diagnosed prostate cancer. What is the ProVent Study? The ProVent study is a randomized, open-label study designed to look at whether sipuleucel-T can slow the progression of prostate cancer for subjects in active surveillance, following sipuleucel-T…
Read more

Prostate Cancer Screening & Treatment

The term “cancer” refers to a condition in which cells accumulate uncontrollably—the ability to regulate cell growth or death is lost. So instead of dying as they should, prostate cancer cells live longer than normal cells and form masses of abnormal cells known as tumors. Primary tumors are the original tumors; secondary tumors occur if…
Read more

Is prostate cancer slow growing?

This year, more than 300,000 American men will be diagnosed with prostate cancer. In most cases, the cancer consists of small knots of abnormal cells growing slowly in the walnut-sized prostate gland. In many men, the cancer cells grow so slowly that they never break free of the gland, spread to distant sites, and pose…
Read more

Are Prostate Cancer Deaths On The Rise?

No, prostate cancer deaths continue to decline among all men, according to the American Cancer Society.  Treatment for both localized, and advanced, prostate cancer has continued to improve. Treatments In fact, in the past 10 years, at least six new treatments have become available and commonly used for patients with advanced prostate cancer, and more…
Read more

Prostate Cancer Clinical Research

Adult Pediatric Urology & Urogynecology, PC has many clinical research programs aimed at finding treatments for urinary disorders, including prostatitis and BPH. The Medical Therapy of Prostate Symptoms (MTOPS) program is studying the results of medical therapy used to treat thousands of men with BPH in several research centers throughout the country. MTOPS will provide valuable…
Read more